Anthropic IPO draws protests over recursive AI and healthcare
ACT UP NY and Ban RSI protested Anthropic’s $81.34 billion IPO over healthcare AI and recursive self-improvement, while a coalition targeted bank investments and founder voting control.

Why it matters
- On November 19, 2026, ACT UP NY and Ban RSI organized separate protests over healthcare AI and recursive self-improvement.
- Anthropic’s IPO priced 980 million Class A shares at $83 each, an $81.34 billion offering.
- The founders’ Founder LLC holds a Class F share with votes equal to 50.1% of general voting power.
- Ban RSI’s San Francisco listing recorded 164 “Went” RSVP accounts, not a verified crowd count.
- The Long-Term Benefit Trust generally elects and removes the Class T directors who constitute a majority of Anthropic’s board.
By Rebecca Stone
Anthropic’s final prospectus priced 980 million Class A shares at $83 each for an $81.34 billion IPO.
On November 19, 2026, as Anthropic entered public markets, ACT UP NY and Ban RSI organized separate demonstrations in New York and San Francisco.
Anthropic’s final prospectus frames Claude’s role in building its successor as “a structural advantage.” ACT UP NY challenged the use of AI in medicine. Ban RSI challenged recursive self-improvement.
The final prospectus also provides that a single Class F share held by the founders’ Founder LLC carries votes equal to 50.1% of general voting power. The Long-Term Benefit Trust generally elects and removes the Class T directors who constitute a majority of the board. Each Class A share carries one vote.
The timing put Anthropic’s development practices and public-benefit governance before public-market investors. The protests asked for verifiable limits on recursive AI work, protections in healthcare and scrutiny of who could direct the company after listing.
The three campaigns reached different parts of the business: clinical deployment, model development and the financing of AI and data-center capacity. The listing placed those questions before shareholders, banks and public financial offices at the same time.
What happened at the New York and San Francisco protests?
ACT UP NY’s action notice called supporters to 4 Times Square at 8:30 a.m. ET, where Anthropic was holding its Nasdaq IPO event. The notice asked supporters to hold an “AI Out Of Our Healthcare” banner, distribute flyers and potentially speak at the rally and to reporters.
The notice said some practices it opposes had already begun in hospitals and doctors’ offices. Its concerns cover four areas:
- AI replacing live medical screening or hospital staff.
- AI influencing treatment and outcomes.
- AI training on health data.
- racial, gender and anti-LGBTQ bias.
Ban RSI’s rally page scheduled a separate gathering outside Anthropic’s office at 500 Howard Street in San Francisco from 11 a.m. to noon Pacific.
The listing showed 164 accounts in its “Went” category, a host-platform RSVP status rather than a verified crowd count. Ban RSI listed former AI researchers Jacob Coxon and Daniel Kokotajlo and AI safety educator Rob Miles as scheduled speakers.
Both groups targeted Anthropic on the same date, but their demands were separate. ACT UP NY addressed the use of AI in care. Ban RSI addressed the process by which more capable systems might be built.
What does Ban RSI want from Anthropic?
Ban RSI defines recursive self-improvement as AI doing the work of building more powerful AI.
The group wants large AI companies barred from using systems more powerful than those available at the rally for AI research. It says an international treaty would be the preferred mechanism.
Its proposed enforcement mechanism would:
- require systems above that threshold to carry safeguards that block the research even inside company laboratories.
- red-team test those safeguards.
- make exceptions for monitoring and safety research that clearly does not increase AI capability.
The group is not demanding a unilateral pause. It wants Anthropic to announce concrete, verifiable steps toward avoiding recursive self-improvement.
Those steps could include urging other AI companies to follow or lobbying for legislation. The demand puts the obligation for the first announcement on Anthropic rather than on peers or a future treaty.
How does Anthropic describe Claude building its successor?
Anthropic’s final prospectus describes “closing the loop” as “a structural advantage.” Successive Claude versions would help build the next through experiments, training-data generation and processing, evaluations, safety audits, and code writing and review.
An Anthropic Institute article says: “full recursive self-improvement, meaning an AI system autonomously designing and developing its own successor, has not arrived and is not inevitable.”
The article says the capability could increase the risk of humans losing control. It identifies a remaining gap in Claude’s judgment about which goals and experiments to pursue, even as Claude takes on more engineering and research work.
The prospectus presents model succession as an internal engineering process. Ban RSI presents the same capability as work that should be restricted.
Would Anthropic pause development?
Anthropic says it would expect to slow down or temporarily pause if other developers at or near the frontier did so verifiably.
Proposed conditions include multiple well-resourced labs in multiple countries and systems that can confirm compliance.
Anthropic argues that a unilateral pause would accomplish less and could change the industry front-runner. That creates a narrow point of agreement with Ban RSI, which also rejects a unilateral-pause demand.
The difference is over the immediate obligation. Protesters want Anthropic to announce verifiable steps itself. The company’s stated expectation to pause depends on reciprocal action.
Verifiability is the common condition, but its trigger differs. Ban RSI wants Anthropic to move first. Anthropic ties any slowdown to verified reciprocal moves.
What are banks and retirement funds being asked to do?
A separate joint petition sponsored by Action Center on Race and the Economy, Stop Funding Billionaires, Climate Defenders and other organizations calls for a boycott of Anthropic’s IPO. It also targets financial institutions over AI investment and the use of retirement savings.
The petition calls for:
- a pause on all AI and data-center investments.
- a pledge not to use taxpayer or retirement money for an AI bailout.
It is addressed to bank executives underwriting or facilitating the offering, state and local financial officers, asset managers and institutional investors, including university endowments and foundations.
By naming banks, public finance offices and asset managers, the petition extends the dispute beyond Anthropic’s shareholders to the institutions that finance AI and data-center investment.
Who controls Anthropic after the IPO?
The IPO gives Class A shareholders one vote per share but leaves general voting power concentrated in the founders’ vehicle. The Class F share’s 50.1% voting share remains intact after pricing.
Board-selection power sits with the Long-Term Benefit Trust, which generally elects and removes the Class T directors who constitute a board majority.
Together, those arrangements create a paired accountability question: whether Anthropic’s development practices can be verifiably constrained and whether its governance will uphold the company’s public-benefit purpose of responsible AI development for humanity’s long-term benefit.
The next test is whether Anthropic announces verifiable safeguards and whether banks, asset managers and institutional investors respond to the petition. Those decisions will show whether Anthropic’s stated public-benefit purpose can be upheld alongside its founder-weighted voting structure.
Source: unite.ai
More from Rebecca Stone
Show full bio
Correspondent covering companies, deals and strategy in artificial intelligence and machine learning at AI In Context.
802 articles
Related articles
- Anthropic's IPO Structure Leaves Public Benefit to Directors' Judgment
- Anthropic's IPO Blueprint Locks Founders and Trust Into Power
- Anthropic Pledges 5% of Shares to Public Benefit Fund Ahead of IPO
- Anthropic Puts 5% of Its Shares Into a 'Public Benefit Fund'
- Seven Anthropic Founders Stand to Make $17 Billion Each at IPO